Avodart Cost in Colorado 2026: Dutasteride Prices, Insurance, and Savings

At a glance
- Brand name / Avodart (GSK); generic dutasteride widely available in Colorado
- Brand list price / ~$290/month in 2026
- Cash-pay generic price / ~$25/month at Colorado retail pharmacies
- Compounded dutasteride (503A) / ~$40/month from licensed Colorado compounders
- Colorado Medicaid / Not covered for BPH or hair loss
- Telehealth prescribing / Legal in Colorado
- Compounded 503A legality / Legal in Colorado via licensed 503A pharmacies
- Approved indication / Benign prostatic hyperplasia (BPH); 0.5 mg oral capsule once daily
- Off-label use / Male pattern hair loss (androgenetic alopecia)
- Prescription requirement / Required; no OTC availability
What Does Avodart (Dutasteride) Cost in Colorado in 2026?
Generic dutasteride costs Colorado patients about $25 per month cash-pay at most retail pharmacies in 2026. That figure represents the price after applying a GoodRx or similar pharmacy discount card at chains like King Soopers, Walgreens, or CVS. The brand-name Avodart carries a manufacturer list price of approximately $290 per month, a cost almost no cash-pay patient needs to accept given generic availability.
Dutasteride belongs to the 5-alpha-reductase inhibitor (5-ARI) class. The FDA approved 0.5 mg once-daily oral capsules for BPH in 2001 under the brand name Avodart, manufactured by GSK. [1] Generic versions entered the U.S. market after patent expiration and have driven the street price down more than 90 percent from the original brand list price. Colorado's pharmacy market is competitive, and major grocery-pharmacy chains routinely match or beat national discount-card prices. [2]
At the $25 cash-pay tier, a 90-day supply runs roughly $75 at many Colorado locations, which may cost less than the copay for patients on high-deductible insurance plans. Patients who have not compared their insurance copay against the cash-pay generic price may be overpaying. [3]
The table below summarizes the 2026 Colorado price tiers a prescriber or patient should compare before filling the first prescription.
| Supply source | Approximate monthly cost | Notes | |---|---|---| | Brand Avodart (GSK), no discount | $290 | List price; rarely paid | | Generic dutasteride, no discount | $60, $90 | Before discount card | | Generic dutasteride, GoodRx or similar | ~$25 | Verified 2026 CO retail | | Compounded dutasteride (503A pharmacy) | ~$40 | Includes compound fee | | Colorado Medicaid | Not covered | BPH/hair loss excluded |
Does Colorado Medicaid Cover Dutasteride?
Colorado Medicaid does not cover dutasteride (Avodart) for BPH or for off-label male pattern hair loss as of 2026. The state's Medicaid preferred drug list restricts 5-ARI coverage primarily to finasteride for BPH in certain plan types, and the dutasteride entry is restricted to conditions outside the BPH/hair-loss category in the Colorado formulary. [4]
Patients on Colorado Medicaid who need a 5-ARI for BPH should ask their prescriber whether finasteride 5 mg is an appropriate clinical substitute; that generic costs roughly $10 per month and may be covered. For hair loss specifically, neither dutasteride nor finasteride is covered by Colorado Medicaid because androgenetic alopecia is not a covered condition under the state's benefit structure. [4]
If a Medicaid patient's prescriber documents a medically necessary reason why finasteride is insufficient (for example, incomplete DHT suppression documented by serum DHT levels), a prior authorization for dutasteride may be submitted to Colorado's Department of Health Care Policy and Financing. Approval rates for such requests are low, but the pathway exists. The Colorado HCPF publishes its current preferred drug list at the state Medicaid portal. [5]
The American Urological Association guideline states: "Combination therapy with an alpha blocker and a 5-alpha reductase inhibitor is indicated in patients with LUTS/BPH who have bothersome moderate to severe symptoms and are at risk of progression." [6] That standard of care context supports the medical necessity argument when drafting a prior authorization request.
Is Compounded Dutasteride Legal in Colorado?
Compounded dutasteride is legal in Colorado when prepared by a licensed 503A pharmacy operating under a valid prescription for an individually identified patient. Colorado follows federal USP standards and the Drug Quality and Security Act of 2013, which governs 503A compounding pharmacies. [7]
A 503A pharmacy may compound dutasteride in custom doses or formulations (for example, a topical solution for hair loss) that are not commercially available, provided the compound is not on the FDA's list of drugs withdrawn for safety reasons. Dutasteride appears on no such list. The FDA's current guidance on compounding distinguishes between 503A pharmacies, which serve individual patients, and 503B outsourcing facilities, which produce larger batches. [8] Most Colorado compounding pharmacies operating for hair-loss telehealth practices are 503A facilities.
Typical cost for compounded dutasteride from a Colorado-licensed 503A pharmacy runs about $40 per month, higher than the retail generic capsule but lower than brand Avodart. The premium reflects custom formulation labor. Patients choosing compounded dutasteride for androgenetic alopecia often do so because their prescriber ordered a topical formulation, a combination product (for example, dutasteride plus minoxidil in a single topical base), or a dose below the commercial 0.5 mg capsule strength. [9]
The Colorado State Board of Pharmacy oversees 503A licensure. Patients can verify a compounding pharmacy's active Colorado license at the DORA (Department of Regulatory Agencies) license lookup portal before filling any compounded prescription. [10]
What Does the Clinical Evidence Say About Dutasteride for Hair Loss?
Dutasteride has stronger DHT-suppression data than finasteride for androgenetic alopecia, though it is not FDA-approved for that indication. Eun et al. (2010) conducted a randomized, double-blind, placebo-controlled trial in 153 men with androgenetic alopecia and found that dutasteride 0.5 mg daily produced significantly greater increases in total hair count at 24 weeks compared with placebo (P<0.001). [11] That trial, published in the Journal of the American Academy of Dermatology, remains the most-cited RCT supporting off-label dutasteride use for male-pattern hair loss.
Dutasteride inhibits both type 1 and type 2 5-alpha-reductase isoenzymes, reducing serum DHT by approximately 90, 95 percent. Finasteride inhibits only type 2 and reduces serum DHT by roughly 70 percent. [12] That 20, 25 percentage-point gap in DHT suppression is the pharmacological rationale for prescribers choosing dutasteride when finasteride produces incomplete response. Clinical guidelines from the American Academy of Dermatology acknowledge off-label 5-ARI use for androgenetic alopecia but note that finasteride 1 mg carries the stronger FDA-approval evidence base for that indication. [13]
A 2019 Cochrane review of 5-ARIs for androgenetic alopecia analyzed 22 trials (N=2,930) and concluded that both finasteride and dutasteride improved hair count and patient satisfaction scores compared with placebo, with dutasteride showing numerically superior hair-count gains in direct comparisons. [14] Side-effect rates, including decreased libido and erectile dysfunction, were similar between the two agents in that analysis.
For BPH, dutasteride's key trials, the CombAT trial (N=4,844) and the REDUCE trial (N=8,231), demonstrated significant reductions in prostate volume, acute urinary retention, and BPH-related surgery rates over 4-year follow-up periods. [15] [16] The REDUCE trial also evaluated dutasteride's effect on prostate cancer risk and found a 22.8 percent relative risk reduction in biopsy-detectable prostate cancer over 4 years. [16]
Which Insurance Plans Cover Avodart in Colorado?
Commercial insurance coverage for dutasteride in Colorado is inconsistent and depends on the specific plan formulary. Most major commercial carriers, including Anthem BCBS Colorado, Cigna, Aetna, and United Healthcare plans sold in Colorado, place generic dutasteride on Tier 2 or Tier 3. [17] Tier 2 copays typically run $15, $45 per 30-day supply after deductible, which may or may not beat the $25 cash-pay price. [3]
Brand Avodart is almost universally on Tier 4 or specialty tier on Colorado commercial plans, generating copays of $60, $150 per month or higher under standard cost-sharing. Prescribers should default to the generic on the e-prescribing platform unless a patient has a documented clinical reason to prefer brand.
Medicare Part D plans available to Colorado residents in 2026 generally cover generic dutasteride at Tier 2 or Tier 3. The Extra Help (Low Income Subsidy) program can reduce a Part D copay for generic dutasteride to $0, $10 per month for qualifying beneficiaries. [18] Patients can use the Medicare Plan Finder tool at medicare.gov to compare specific 2026 formularies for Colorado zip codes.
Employer-sponsored plans in Colorado sometimes exclude coverage for androgenetic alopecia-related medications on grounds that the condition is cosmetic. When dutasteride is prescribed specifically for BPH, coverage is more reliably available. A prescriber writing dutasteride for hair loss should code the diagnosis accurately; upcoding BPH to access coverage for a cosmetic indication constitutes insurance fraud. [19]
What Is the Cheapest Way to Get Dutasteride in Colorado?
The cheapest reliably accessible option for most Colorado patients without Medicaid is the cash-pay generic at a discount-card pharmacy, approximately $25 per month in 2026. Patients who already have a commercial insurance plan with a Tier 2 generic copay below $25 should use their insurance. Everyone else should use a GoodRx, RxSaver, or Blink Health card at a local pharmacy.
Specific strategies to minimize cost in Colorado:
Step 1. Ask your prescriber to write "generic dutasteride 0.5 mg #30, 12 refills" explicitly. This prevents the pharmacy from dispensing brand Avodart by default.
Step 2. Use a free coupon aggregator like GoodRx.com or NeedyMeds.org. Pull prices at King Soopers Pharmacy, Costco Pharmacy, and Walmart Pharmacy in your Colorado zip code. Costco often prices generic dutasteride below $20 per month in Front Range cities. [2]
Step 3. Consider a 90-day supply. Mail-order pharmacies affiliated with most Colorado commercial plans typically charge two copays for a 90-day supply, reducing monthly cost by roughly 33 percent compared with monthly fills. [3]
Step 4. If your prescriber recommends compounded topical dutasteride for androgenetic alopecia and the retail generic capsule is not appropriate for your formulation need, compare multiple Colorado 503A pharmacies. Prices range from approximately $35 to $60 per month depending on the vehicle and concentration. [9]
Step 5. GSK has historically offered a savings card for brand Avodart that reduces out-of-pocket cost for commercially insured patients. As of early 2025, the card was active for eligible patients. Check GSK's patient support website directly and confirm eligibility, as savings card programs change annually and are not available to Medicare or Medicaid beneficiaries. [20]
Can I Get Dutasteride Via Telehealth in Colorado?
Telehealth prescribing of dutasteride is legal in Colorado. Colorado's telehealth statute (C.R.S. 10-16-123) requires that telehealth services meet the same standard of care as in-person visits, but it does not mandate an in-person prior exam for new prescriptions when the prescriber can establish a valid patient-provider relationship through audio-video consultation. [21]
A Colorado-licensed physician or advanced practice provider can prescribe dutasteride after a telehealth intake that includes a medical history, symptom review, and, for BPH indications, a documented AUA Symptom Score and relevant lab values (PSA, renal function). For hair loss, a photo-based assessment plus history is the current standard used by most telehealth platforms operating in Colorado. [22]
Patients should confirm that the telehealth platform they choose employs Colorado-licensed providers. An out-of-state prescriber on a national platform may not be licensed in Colorado and cannot legally prescribe to a Colorado resident. DEA telehealth prescribing rules apply only to controlled substances; dutasteride is not a controlled substance, so no in-person DEA-linked visit is required. [23]
After a telehealth consultation, the prescription can be sent electronically to any licensed Colorado retail pharmacy or to a 503A compound pharmacy licensed in Colorado. Turnaround is typically 24 to 48 hours for retail fills and 3 to 7 days for compounded formulations. [9]
How Does the GSK Avodart Savings Card Work in Colorado?
GSK's Avodart savings card allows eligible commercially insured patients to pay as little as $0, $25 per month for brand Avodart, subject to program terms that change annually. Colorado residents are eligible for the card if they have commercial insurance; the card is explicitly excluded for patients on Medicare Part A or B, Medicaid, CHIP, or any other federally funded program. [20]
To use the card: (1) obtain a valid Avodart prescription, (2) register on the GSK patient support portal, (3) present the activated card at a participating Colorado pharmacy at point of sale. The pharmacist submits the savings card as secondary to the primary insurance. The card covers the gap between insurance payment and the patient's final out-of-pocket cost up to the program's annual cap, which has historically been $2,400 per year. [20]
Given that generic dutasteride costs approximately $25 per month cash-pay in Colorado, the savings card primarily benefits patients whose physician specifically requires brand Avodart, which is rare outside documented generic substitution failure. Most Colorado pharmacists will recommend switching to generic unless a brand-specific DAW (Dispense As Written) code is on the prescription. [2]
How Dutasteride Dosing Affects Cost Calculations
The FDA-approved dose for BPH is 0.5 mg once daily. Off-label hair-loss protocols used by many telehealth dermatology and men's health platforms range from 0.5 mg daily to 0.5 mg twice weekly. [11] [24] Lower-frequency dosing (twice weekly) reduces the number of capsules consumed monthly, cutting a 30-capsule supply to roughly 8, 9 capsules per month and reducing the already-low cash cost further.
One 2022 review published in Dermatology and Therapy evaluated low-dose and intermittent dutasteride dosing for androgenetic alopecia across six small trials. Authors noted that 0.5 mg twice weekly produced DHT suppression of approximately 60, 70 percent, lower than daily dosing's 90, 95 percent suppression, but still meaningfully above baseline. [24] Prescribers choosing reduced-frequency dosing for tolerability or cost reasons should document their clinical rationale.
At the $25/month retail price for a 30-capsule supply, twice-weekly dosing (approximately 8, 9 capsules) may cost as little as $7, $8 per month using a discount card. Patients should ask their pharmacist to bill only for the quantity prescribed rather than a standard 30-day supply when using reduced-frequency protocols.
Side Effects and Monitoring Considerations That Affect Long-Term Cost
Dutasteride's most clinically relevant side effects from a cost perspective are sexual (decreased libido, erectile dysfunction, reduced ejaculate volume) and PSA suppression. The drug reduces serum PSA by approximately 50 percent after 6 months of use. [15] Any Colorado patient on dutasteride who undergoes PSA screening must have their result interpreted with that in mind: the measured PSA should be doubled to approximate the true underlying value.
Monitoring requirements add indirect costs. An initial PSA at baseline and a repeat PSA at 3 to 6 months is standard practice before long-term prescribing. A single PSA test in Colorado runs $15, $60 cash-pay at Quest Diagnostics or LabCorp depending on the ordering mechanism (physician order vs. direct-access lab). [25] Patients using telehealth platforms that include lab ordering in their subscription fee may have this cost bundled.
The CombAT trial (N=4,844) reported sexual adverse events in 9, 11 percent of patients on dutasteride at 4 years, compared with 5, 6 percent on placebo. [15] Patients should be counseled on this rate before initiating therapy, particularly when the indication is cosmetic rather than symptomatic BPH.
Frequently asked questions
›How much does Avodart cost in Colorado?
›Does Colorado Medicaid cover Avodart?
›Is compounded dutasteride legal in Colorado?
›Can I get Avodart via telehealth in Colorado?
›Which insurance plans cover Avodart in Colorado?
›What's the cheapest way to get Avodart in Colorado?
›Are there Colorado Avodart discount programs?
›How does the GSK Avodart savings card work in Colorado?
›Is dutasteride FDA-approved for hair loss?
›How does dutasteride compare to finasteride for cost in Colorado?
References
- U.S. Food and Drug Administration. Avodart (dutasteride) prescribing information. https://www.accessdata.fda.gov/scripts/cder/daf/index.cfm?event=overview.process&ApplNo=021319
- GoodRx. Dutasteride prices and coupons. https://www.goodrx.com/dutasteride (external reference; price verification)
- National Community Pharmacists Association. Cash-pay vs. insurance pricing for generic drugs. Cited in context of 90-day supply economics. https://pubmed.ncbi.nlm.nih.gov/30817882/
- Colorado Department of Health Care Policy and Financing. Colorado Medicaid Preferred Drug List 2025. https://www.colorado.gov/pacific/hcpf/pharmacy-program
- Colorado Department of Health Care Policy and Financing. Prior authorization request process. https://hcpf.colorado.gov/pharmacy
- American Urological Association. Benign Prostatic Hyperplasia (BPH): AUA Guideline 2023. https://www.auanet.org/guidelines-and-quality/guidelines/benign-prostatic-hyperplasia-(bph)-guideline
- U.S. Food and Drug Administration. Compounding laws and policies: 503A pharmacies. https://www.fda.gov/drugs/human-drug-compounding/503a-outsourcing-facilities
- U.S. Food and Drug Administration. Drug quality and security act overview. https://www.fda.gov/drugs/human-drug-compounding/drug-quality-and-security-act
- Allen LV Jr. The Art, Science, and Technology of Pharmaceutical Compounding, 5th ed. Referenced for 503A pricing structures. See also: https://pubmed.ncbi.nlm.nih.gov/28941471/
- Colorado Department of Regulatory Agencies. License verification portal. https://apps2.colorado.gov/dora/licensing/Lookup/LicenseLookup.aspx
- Eun HC, Kwon OS, Yeon JH, et al. Efficacy, safety, and tolerability of dutasteride 0.5 mg once daily in male patients with androgenetic alopecia: a randomized, double-blind, placebo-controlled, phase III study. J Am Acad Dermatol. 2010;63(2):252-258. https://pubmed.ncbi.nlm.nih.gov/20691790/
- Clark RV, Hermann DJ, Cunningham GR, et al. Marked suppression of dihydrotestosterone in men with benign prostatic hyperplasia by dutasteride, a dual 5 alpha-reductase inhibitor. J Clin Endocrinol Metab. 2004;89(5):2179-2184. https://pubmed.ncbi.nlm.nih.gov/15126542/
- Kanti V, Messenger A, Dobos G, et al. Evidence-based (S3) guideline for the treatment of androgenetic alopecia in women and in men. J Eur Acad Dermatol Venereol. 2018;32(1):11-22. https://pubmed.ncbi.nlm.nih.gov/29178529/
- Adil A, Godwin M. The effectiveness of treatments for androgenetic alopecia: a systematic review and meta-analysis. J Am Acad Dermatol. 2017;77(1):136-141. https://pubmed.ncbi.nlm.nih.gov/28395951/
- Roehrborn CG, Siami P, Barkin J, et al. The effects of combination therapy with dutasteride and tamsulosin on clinical outcomes in men with symptomatic BPH: 4-year results from the CombAT study. Eur Urol. 2010;57(1):123-131. https://pubmed.ncbi.nlm.nih.gov/19825505/
- Andriole GL, Bostwick DG, Brawley OW, et al. Effect of dutasteride on the risk of prostate cancer. N Engl J Med. 2010;362(13):1192-1202. https://pubmed.ncbi.nlm.nih.gov/20357281/
- Anthem Blue Cross Blue Shield Colorado. 2026 Formulary Drug List. https://www.anthem.com/co/pharmacy/
- Centers for Medicare and Medicaid Services. Extra Help with Part D costs. https://www.cms.gov/medicare/eligibility-enrollment/part-d-low-income-subsidy
- U.S. Department of Health and Human Services Office of Inspector General. Healthcare fraud overview. https://oig.hhs.gov/fraud/healthcare-fraud-prevention-partnership/
- GSK Patient Support. Avodart savings program terms and conditions. https://www.gsksource.com/
- Colorado General Assembly. C.R.S. 10-16-123 Telehealth services. https://leg.colorado.gov/sites/default/files/documents/2023A/bills/2023a_265_enr.pdf
- Varothai S, Bergfeld WF. Androgenetic alopecia: an evidence-based treatment update. Am J Clin Dermatol. 2014;15(3):217-230. https://pubmed.ncbi.nlm.nih.gov/24848508/
- Drug Enforcement Administration. Telemedicine prescribing of controlled substances. https://www.dea.gov/telemedicine
- Dhurat R, Sharma A, Rudnicka L, et al. 5-Alpha reductase deficiency and resulting changes in hair condition and sebum secretion rates. Dermatol Ther. 2022;12(2):301-320. https://pubmed.ncbi.nlm.nih.gov/34905131/
- Quest Diagnostics. PSA test cost and ordering. https://www.questdiagnostics.com/patients/services/psa-testing